Following the success of our investor event at the Swedish Embassy in Madrid, we invite you to an exclusive webinar on March 5th, 2025, at 18:00 CET. Hosted by the Spanish-Swedish Chamber of Commerce, this session will showcase how VERIGRAFT is revolutionizing transplantation medicine with personalized tissue-engineered grafts that eliminate the need for immunosuppression.
Looking for an early-stage investment in a groundbreaking biotech company? Hear from CEO Petter Björquist and CTO Raimund Strehl, and explore investment opportunities starting at 1,000€.
Register now to secure your spot: https://us02web.zoom.us/meeting/register/nuQ_qkBzTLeURxhnx0EMcg